5 terminated. 5 Phase 2, 2 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 5 | Terminated 5 |
| Phase 1 | 2 | Terminated 2 |
Follow Transarterial chemoembolization: new trials by email Literature Review of Transarterial chemoembolization trials Research Report on Transarterial chemoembolization
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Atezolizumab and Bevacizumab in Combination With TACE for Patients With BCLC B HCC Atezolizumab Injection, Bevacizumab, Transarterial chemoembolization - Hepatocellular Carcinoma, BCLC Stage B Hepatocellular Carcinoma | Phase 2 | Terminated | Yale University | 3 | 2023-06-07 | 2025-01-15 |
| Evaluate the Effect of Tirazamine on Primary Liver Cancer. tirapazamine, Transarterial Embolization, TACE - Hepato Cellular Carcinoma (HCC) | Phase 1 / Phase 2 | Terminated | Zhejiang Raygene Pharmaceuticals Co., Ltd | 16 | 2021-05-14 | 2025-02-27 |
| Perioperative Therapy for Hepatocellular Carcinoma Sintilimab Injection, TACE, Radiotherapy - Hepatocellular Carcinoma | Phase 2 | Terminated | Zhejiang University | 10 | 2020-12-26 | 2022-01-11 |
| Combination SBRT With TACE for Unresectable Hepatocellular Carcinoma TACE, SBRT - Carcinoma, Hepatocellular, Hepatobiliary Neoplasm | Phase 1 / Phase 2 | Terminated | Stanford University | 11 | 2009-09-01 | 2016-07-27 |
| Effectiveness and Safety Study of TACE Plus Oral Sorafenib for Unresectable HCC Sorafenib, TACE - Carcinoma, Hepatocellular | Phase 2 | Terminated | University of Pittsburgh | 19 | 2008-01-01 | 2017-02-15 |
Carcinoma, Hepatocellular (5) · Carcinoma (1)
Stanford University (1) · University of Pittsburgh (1) · Yale University (1) · Zhejiang Raygene Pharmaceuticals Co., Ltd (1) · Zhejiang University (1)
United States (3) · China (2)
Caifang Ni, M.D (1) · Daniel T Chang (1) · Stacy Stein, MD (1) · Thomas C Gamblin, MD (1)